Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
about
Optimum second-line regimens for Helicobacter pylori eradicationSequential versus standard triple first-line therapy forHelicobacter pylorieradicationNon-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradicationSystematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.Role of dietary polyphenols in the management of peptic ulcerEfficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradicationEffects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from ChinaSeven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.Is concomitant quadruple therapy for Helicobacter pylori eradication really needed for Japanese patients?Changes in Antibiotic Susceptibility of Helicobacter pylori in the Course of Eight Years in the Zaanstreek Region in The NetherlandsSequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis.Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind studyRabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study.Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled TrialReview article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection.Treatment of Helicobacter pylori infection 2012.A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).Evidence-based recommendations for successful Helicobacter pylori treatment.Helicobacter pylori: management in 2013.Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.Resistance mechanism to an uncompetitive inhibitor of a single-substrate, single-product enzyme: a study of Helicobacter pylori glutamate racemase.Outcome of second- and third-line Helicobacter pylori eradication therapies based on antimicrobial susceptibility testing.Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy.Rescue Therapy for Helicobacter pylori Infection 2012.Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes.Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.Commentary: comparators in H. pylori eradication--stating the ethics of statins.Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.First-line eradication rates comparing two shortened non-bismuth quadruple regimens against Helicobacter pylori: an open-label, randomized, multicentre clinical trial.Dealing with uncertainty in the treatment of Helicobacter pylori.Comparison of the efficacy and safety of hybrid and sequential therapies as a first-line regimen for Helicobacter pylori infection in Turkey.Effectiveness of Helicobacter pylori eradication established on the basis of examination of antibiotic resistance of the bacteria.Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication: A prospective, observational study
P2860
Q24193213-245DC324-CE5F-42F6-8AA2-1BDC5F9D9A63Q26471410-47CF2883-2DD0-46DE-9498-5C05E2EF5042Q27006833-BC52EE7E-7EE6-42E2-920D-9FBB8CEE9D87Q27322371-C0C8E5F9-D734-4705-A330-65158E13443DQ28088459-0518D7FC-5EC4-405C-B4A4-86EC6CA163DCQ35771863-40EA3CC4-FD7A-4468-BC12-EA43AF50D457Q36067627-AA81FAE8-80CE-460C-8985-C6CC03447665Q36168093-5C72973F-5FCA-4F9F-9A96-1C3E2E043BF6Q36360817-E6329612-CB2D-4AED-9600-AD1B702C5A72Q36681346-C3C8DB74-3C69-43F3-9C3F-1ED0FA1ECD2DQ36723178-47211FE2-5791-4B8F-A7EE-87F99582CFACQ37066366-3B7EDC82-2976-4A54-972F-6C6FC518F6A8Q37110475-0CBCC131-322C-4C85-9C9B-D20FBE68CA23Q37282589-FE6F5C52-AB62-4292-B96A-03E4807D633FQ37682524-EF8D092A-FD29-4CBB-B272-2D29B2EB948DQ37699963-1C967C7B-163A-4F07-AEA7-CE440E2C1E1EQ38014922-7248F445-A415-4E07-9A26-EF685420C7B8Q38041644-B5676C58-99F1-4FD8-B1AF-9353673C6CE7Q38093864-992D3893-6784-4185-9068-1D7943E20501Q38177322-34200B43-3120-49FD-9BEE-414180F5EF8CQ38212214-934DB131-2139-469B-9E83-21D9624558FEQ38865607-C82FC62F-0DBA-425B-9CBD-68A978CEBD9EQ39196966-928EBC55-408F-4548-AFE0-7C705AA9010AQ39278632-D952C554-ED63-4A4F-8967-519227FC6C35Q39383708-3E16ECF5-7B9D-49BE-8577-D48B75AA5E1CQ41070434-8932BE55-7C1A-416B-AD93-B96F3B2AF700Q41471323-61A842BD-510E-4A8A-81F5-17CC800B6204Q41694687-EDFA6301-3B78-4540-9692-453F87734829Q42129420-AD058C40-7BC5-4F72-9D35-41009CD8EC1CQ42718660-428B873F-0BF3-465D-8F09-2ABEB7224E1BQ44224887-5ECE9C80-ABBE-4B90-976F-3AF6039E3BE5Q44284215-20920C1A-E4E9-4F94-9011-E9971C63823EQ44530388-33018315-4A3F-4DF8-B3F7-EBF2A72793A1Q48203004-BE6213D1-FBFE-47FA-A045-E7E4E404B485Q50448522-C6F80F89-B802-4337-8FA5-51AB6EA8B41AQ52330458-179461D9-49E4-44EE-AD32-6A5EA1A87D71Q55401337-3178587A-7506-4570-87F9-741A0881A354Q55617245-19BF9B9A-9471-487B-9E79-D5E7FBBCFC82Q57929706-F21159E8-0FB8-450A-B3B8-922EDA649CBC
P2860
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review article: the effectiven ...... de, but it is not good enough.
@en
Review article: the effectiven ...... de, but it is not good enough.
@nl
type
label
Review article: the effectiven ...... de, but it is not good enough.
@en
Review article: the effectiven ...... de, but it is not good enough.
@nl
prefLabel
Review article: the effectiven ...... de, but it is not good enough.
@en
Review article: the effectiven ...... de, but it is not good enough.
@nl
P2860
P50
P1476
Review article: the effectiven ...... ade, but it is not good enough
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2011.04887.X
P407
P577
2011-10-21T00:00:00Z